LENZ Therapeutics, Inc. (LENZ) › Shareholders' EquityLENZ Therapeutics, Inc. (LENZ) — Shareholders' EquityAnnual figures by period end, from SEC filings.2019-12-31: -$2.22M2020-12-31: -$65.41M2021-12-31: $384.05M2022-12-31: -$24.17M2023-12-31: -$92.71M2024-12-31: $204.08M2025-12-31: $284.34M$284.34M2019-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$284.34M+39.3%2026-03-24Balance as of period end2024-12-31$204.08M—2026-03-24Balance as of period end2023-12-31-$92.71M—2026-03-24Balance as of period end2022-12-31-$24.17M-106.3%2025-03-19Balance as of period end2021-12-31$384.05M—2024-02-27Balance as of period end2020-12-31-$65.41M—2023-03-20Balance as of period end2019-12-31-$2.22M—2022-03-21Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)